EUVIMEDEUVIMED entdecken
Crossref

Attitudes, satisfaction and experience with administration of progesterone for assisted reproductive treatment

Maria Borgstrøm, Bugge Nøhr, Ulrik Schiøler Kesmodel

Danish Medical Journal · 2026

DOI: 10.61409/a05250447 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Danish Medical Journal, 2026. Verfasst von Maria Borgstrøm und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Fertility Clinic, Department of Obstetrics and Gynaecology, Copenhagen University Hospital - Herlev and Gentofte Hospital. Hauptthemen laut MEDLINE: Progesterone, Patient Satisfaction, Reproductive Techniques, Assisted, Progestins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION. Progesterone as luteal phase support is challenging as there is no consensus on whether and how it should be used in different types of fertility treatments, the timing of initiation, dosage, duration of use and form of administration. This study aimed to explore women’s attitudes, level of satisfaction and experiences with subcutaneous injection of progesterone (25 mg/day for two weeks) after prior vaginal administration of progesterone in assisted reproductive technology treatments. METHODS. This was a cross-sectional study recruiting women planned for a treatment with progesterone from two public fertility clinics in Denmark. Only women with at least one previous blastocyst transfer using vaginal progesterone were recruited. Questionnaires covered side effects, medication, daily activities, and sex and intimacy. RESULTS. The study had a response rate of 80%, with 100 women participating. Among these, 82% (95% CI: 73-89%) were satisfied (to either a very high or high degree) with the subcutaneous form of their progesterone medication in their current treatment compared with vaginal progesterone in earlier treatments. Furthermore, 84% (95% CI: 75-91%) would choose subcutaneous over vaginal progesterone in future treatments if given the option, whereas 8% (95% CI: 4-15%) preferred the vaginal form. CONCLUSIONS. When comparing experiences with subcutaneous to vaginal administration, our findings showed that subcutaneous progesterone is a suitable alternative for women who are dissatisfied with vaginal administration. If given the opportunity to decide, many would choose the subcutaneous form in future ART treatments. FUNDING. IBSA Nordic. TRIAL REGISTRATION. None.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgesteronePatient SatisfactionReproductive Techniques, AssistedProgestinsHumansFemaleCross-Sectional StudiesAdultAdministration, IntravaginalDenmarkInjections, SubcutaneousSurveys and QuestionnairesLuteal Phase

Substanzen

ProgesteroneProgestins

Autor:innen und Institutionen

  • The Fertility Clinic, Department of Obstetrics and Gynaecology, Copenhagen University Hospital - Herlev and Gentofte Hospital.
  • The Fertility Unit, Aalborg University Hospital.
  • Department of Clinical Medicine, Aalborg University, Denmark.

Zitieren

APA

Borgstrøm, M., Nøhr, B., & Kesmodel, U. S. (2026). Attitudes, satisfaction and experience with administration of progesterone for assisted reproductive treatment. Danish Medical Journal. https://doi.org/10.61409/a05250447

Vancouver

Borgstrøm M, Nøhr B, Kesmodel US. Attitudes, satisfaction and experience with administration of progesterone for assisted reproductive treatment. Danish Medical Journal. 2026. doi:10.61409/a05250447

BibTeX
@article{Borgstrm2026,
  author = {Borgstrøm, Maria and Nøhr, Bugge and Kesmodel, Ulrik Schiøler},
  title = {Attitudes, satisfaction and experience with administration of progesterone for assisted reproductive treatment},
  journal = {Danish Medical Journal},
  year = {2026},
  doi = {10.61409/a05250447}
}
Kostenlos starten →